Cardiac allograft vasculopathy laboratory findings: Difference between revisions
(Created page with "__NOTOC__ {{Cardiac allograft vasculopathy}} {{CMG}} {{AE}} {{AN}} {{RT}} ==Overview== Multiple biomarkers like C-reactive protein, von Willebrand factor and NT-pro...") |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Multiple biomarkers | Multiple biomarkers such as [[C-reactive protein]], [[von Willebrand factor]] and [[NT-pro-BNP]] are used to predict all cause mortality in patients with CAV. Elevated levels of each of these biomarkers signify increased risk of developing CAV. Further research is warranted to help identify the role of biomarkers in diagnosing and predicting CAV<ref name="pmid17519779">{{cite journal| author=Arora S, Gullestad L, Wergeland R, Simonsen S, Holm T, Hognestad A et al.| title=Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation. | journal=Transplantation | year= 2007 | volume= 83 | issue= 10 | pages= 1308-15 | pmid=17519779 | doi=10.1097/01.tp.0000263338.39555.21 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17519779 }} </ref>. | ||
==References== | ==References== |
Latest revision as of 20:24, 28 December 2014
Cardiac allograft vasculopathy Microchapters |
Differentiating Cardiac allograft vasculopathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cardiac allograft vasculopathy laboratory findings On the Web |
American Roentgen Ray Society Images of Cardiac allograft vasculopathy laboratory findings |
Cardiac allograft vasculopathy laboratory findings in the news |
Directions to Hospitals Treating Cardiac allograft vasculopathy |
Risk calculators and risk factors for Cardiac allograft vasculopathy laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2] Raviteja Guddeti, M.B.B.S. [3]
Overview
Multiple biomarkers such as C-reactive protein, von Willebrand factor and NT-pro-BNP are used to predict all cause mortality in patients with CAV. Elevated levels of each of these biomarkers signify increased risk of developing CAV. Further research is warranted to help identify the role of biomarkers in diagnosing and predicting CAV[1].
References
- ↑ Arora S, Gullestad L, Wergeland R, Simonsen S, Holm T, Hognestad A; et al. (2007). "Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation". Transplantation. 83 (10): 1308–15. doi:10.1097/01.tp.0000263338.39555.21. PMID 17519779.